Gilead Acquires Tubulis for Over $3 Billion to Boost Oncology Portfolio
In a significant move to enhance its oncology pipeline, Gilead has announced the acquisition of Tubulis, a German biotech firm, for more than $3 billion.
In a significant move to enhance its oncology pipeline, Gilead has announced the acquisition of Tubulis, a German biotech firm, for more than $3 billion.
Strategic angle: Shareholders approve the merger between OceanFirst and Flushing.
Strategic angle: Trump's shipping waiver does not boost oil flows within US; fuel exports soar Reuters
Strategic angle: Metals mining in Alaska still a big source of jobs, money and exports, report says Alaska Public Media
Strategic angle: Dodge CEO Matt McAlear said a sub-$30,000 performance car would make a lot of sense.
Strategic angle: Insights from Roundtable CEO on strategic direction and financial structure.
Strategic angle: ASML's financial outlook suggests significant revenue growth on the horizon.
Strategic angle: Goldman Sachs cautions tech workers facing layoffs about the challenges of job searching and potential earnings loss.
Strategic angle: PDD Holdings announces its financial results for 2025, revealing a significant revenue figure but a decline in net income.
Strategic angle: Shipping data reveals a tanker carrying Iraqi crude oil has successfully navigated the Strait of Hormuz.
Strategic angle: Jim Cramer highlights the leadership of Intel's CEO in a recent commentary.
Strategic angle: Jim Cramer analyzes the strategies employed by Starbucks' CEO to revitalize the brand.
Strategic angle: Nike's strategic decision aims to address excess inventory and set the stage for recovery.
Strategic angle: The niece and grand-niece of Qasem Soleimani are in the custody of US Immigration and Customs Enforcement, officials said.
A draft resolution aims to authorize defensive measures in response to Iranian disruptions in the Strait of Hormuz.
Strategic angle: Exclusive research reveals minimal impact of new drilling fields on UK's gas import reliance.
Strategic angle: U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in coming and unpredictable.
Strategic angle: The $700 million acquisition of Chemaf highlights a strategic move in US mining diplomacy amid rising competition with China.
Strategic angle: Amid significant layoffs, Oracle has submitted thousands of H-1B visa petitions.
Strategic angle: Congress is expected to resist the proposed reduction in funding for the National Institutes of Health.